Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?

We assessed the impact of new antineoplastic agents on the overall survival (OS) of advanced non-small cell lung cancer (aNSCLC) patients followed up until 2012. Multivariate regression models were run for OS (outcome) and four proxies for innovation (exposure): Index (InnovInd, for SEER-Research da...

Descripción completa

Detalles Bibliográficos
Autores principales: Justo, Nahila, Nilsson, Jonas, Korytowsky, Beata, Dalen, Johan, Madison, Terri, McGuire, Alistair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217468/
https://www.ncbi.nlm.nih.gov/pubmed/32396541
http://dx.doi.org/10.1371/journal.pone.0232669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217468/
https://www.ncbi.nlm.nih.gov/pubmed/32396541
http://dx.doi.org/10.1371/journal.pone.0232669

Ejemplares similares